Disney Stock Trends Bullish Ahead Of Q2 Earnings, Analysts See Almost 23% Upside

The Walt Disney Co (NYSE:DIS) will be reporting its second-quarter earnings on Tuesday, May 7. Wall Street expects $1.10 in earnings per share (EPS) and $22.12 billion in revenues as the company reports before market hours. The stock is up 12.69%% over the past year — more than 25.8% year-to-date. Let’s look at what the […]

Oil settles down on US jobs data, steepest weekly loss in 3 months

By Nicole Jao NEW YORK (Reuters) -Oil prices settled lower on Friday, and posted their steepest weekly loss in three months as investors weighed weak U.S. jobs data and possible timing of a Federal Reserve interest rate cut. Brent crude futures for July settled 71 cents lower, or 0.85%, to $82.96 a barrel. U.S. West […]

Top 4 Industrials Stocks That May Collapse This Quarter

As of April 29, 2024, four stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go […]

US probes Tesla recall of 2 million vehicles over Autopilot, citing concerns

By David Shepardson WASHINGTON (Reuters) -U.S. auto safety regulators said on Friday they have opened an investigation into whether Tesla’s recall of more than 2 million vehicles announced in December to install new Autopilot safeguards is adequate following a series of crashes. The National Highway Traffic Safety Administration (NHTSA) said it opened the probe after […]

Top deals in the global mining sector (April 25)

(Corrects APRIL 25 Factbox to show Nippon Steel-U.S Steel is a proposed deal awaiting regulatory approval, bullet point 4) (Reuters) -BHP Group has bid $38.8 billion for smaller rival Anglo American, offering a deal to forge the world’s biggest copper miner. Here is a list of some previous big-ticket deals in the mining sector: – […]

Biogen cost cuts drive profit beat, as Alzheimer’s drug off to slow start

By Manas Mishra and Sriparna Roy (Reuters) -Biogen reported a quarterly profit that topped Wall Street estimates, helped by cost cutting, as the launch of its new Alzheimer’s disease drug remained sluggish. Sales of Alzheimer’s drug Leqembi, recorded by Japanese partner Eisai, were just $19 million for the quarter, compared to analysts’ tempered expectations of […]

    Newsletter